Garber J, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 2012;18:988–1028.Web of ScienceCrossrefGoogle Scholar
McLachlan SM, Rapoport B. Thyrotropin-blocking autoantibodies and thyroid stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid 2013;23:14–24.PubMedWeb of ScienceCrossrefGoogle Scholar
Diana T, Krause J, Olivo PD, König J, Kanitz M, Decallonne B, et al. Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease. Clin Exp Immunol 2017;189:304–9.CrossrefPubMedWeb of ScienceGoogle Scholar
Massart C, Orgiazzi J, Maugendre D. Clinical validity of a new commercial method for detection of TSH-receptor bindingantibodies in sera from patients with Graves’ disease treated with antithyroid drugs. Clin Chim Acta 2001;304:39–47.CrossrefPubMedGoogle Scholar
Takasu N, Yamada T, Takasu M, Komiya I, Nagasawa Y, Asawa T, et al. Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. N Engl J Med 1992;326:513–8.CrossrefPubMedGoogle Scholar
Sato K, Okamura K, Yoshinari M, Ikenoue H, Kuroda T, Torisu M, et al. Goitrous hypothyroidism with blocking or stimulating thyrotropin binding inhibitor immunoglobulins. J Clin Endocrinol Metab 1990;71:855–60.PubMedCrossrefGoogle Scholar
Yoshida S, Takamatsu J, Kuma K, Ohsawa N. Thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies during the pregnancy and postpartum period: a case report. Thyroid 1992;2:27–30.CrossrefPubMedGoogle Scholar
Carlé A, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Jørgensen T, et al. Thyroid volume in hypothyroidism due to autoimmune disease follows a unimodal distribution: evidence against primary thyroid atrophy and autoimmune thyroiditis being distinct diseases. J Clin Endocrinol Metab 2009;94:833–9.Web of ScienceCrossrefGoogle Scholar
Daikeler T, Labopin M, Di Gioia M, Abinun M, Alexander T, Miniati I, et al. Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party. Blood 2011;118:1693–8.Web of SciencePubMedCrossrefGoogle Scholar
About the article
Published Online: 2019-03-08
Published in Print: 2019-08-27
Author contributions: AJ and SE wrote the paper, collected data and searched the literature. MD and LP performed the biological assays. SE, LG, FD, SM, JLW, and MCV examined the patients. SE and MCV supervised the work. All authors interpreted the data and contributed to the final version of the manuscript. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
Author disclosure statement: The authors have nothing to disclose concerning this study.